Retatrutide
Pre-approval Expanded Access of Retatrutide (LY3437943)
Eli Lilly · Phase n/r · Available · Enrollment n/r
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Registry arm not named | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Retatrutide
Eli Lilly · Phase n/r · Available · Enrollment n/r
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Registry arm not named | Obesity or overweight | n/r | n/r | n/r | n/r |